Levels of E6-AP are decreased prior to the onset of neurodegeneration in a mouse model of ALS expressing mutant SOD1, and over-expression of E6-AP reduces the aggregation of mutant SOD1 in vitro (Mishra et al., 2013). Here, UBE3A is linked to amyotrophic lateral sclerosis.